Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication

Journal of Virology(2023)10.1128/jvi.01987-22Source: DataRank Database

Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication is a research paper published in Journal of Virology (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.80)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ryota Masuzaki ORCID,Hiroaki Okamoto ORCID,Toshikatsu Shibata ORCID,Mitsuhiko Moriyama ORCID,Hirofumi Kogure ORCID

Live enrichment

PubMed:36728416 PMC:PMC9973044 OpenAlex:https://openalex.org/W4318931880

Japan Agency for Medical Research and Development

Grant: JP22fk0210075

FWCI

1.80

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9973044/pdf/jvi.01987-22.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.01987-22

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9973044

journalhttps://doi.org/10.1128/jvi.01987-22

Fields of Study

Hepatitis C virus researchHepatitis Viruses Studies and EpidemiologyViral Infections and Immunology ResearchHumansDrug Evaluation, PreclinicalHepatitis AHepatitis A virusNiacinamideProtein BiosynthesisTranscription Factor AP-1Virus ReplicationProto-Oncogene Proteins c-jun

MeSH Terms

Drug Evaluation, PreclinicalHepatitis AHumansNiacinamideProtein BiosynthesisVirus ReplicationProto-Oncogene Proteins c-junTranscription Factor AP-1Hepatitis A virus

Keywords

BiologyVirologyNicotinamideNiacinViral replicationInternal ribosome entry siteDrug repositioningThiamine pyrophosphateTranslation (biology)DrugVirusEnzymePharmacologyGeneticsBiochemistryMessenger RNAGeneCofactorHepatitis A virusc-junIRESAP-1

Sustainable Development Goals

SDG 0: Good health and well-being

Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication

FAIR Checklist

Authors (7)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)